Fighting Leucodystrophies Through Research and Awareness
Association Européenne contre les Leucodystrophies (ELA) (ela-asso.com) earns a Brand Analyzer score of 71 out of 100, placing it in the Brand-Ready tier among Non-profit brands, Healthcare brands. Among 632 Non-profit brands analyzed, Association Européenne contre les Leucodystrophies (ELA) ranks in the 70th percentile (category average 67, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 75/100, Digital Presence 82/100, Visual Identity 96/100, Messaging Clarity 100/100, Trust Foundation 70/100, AI Discoverability 71/100, Brand Authority 30/100.
The Association Européenne contre les Leucodystrophies (ELA) is a European non-profit organization dedicated to combating leucodystrophies, a group of rare genetic diseases affecting children. With over 30 years of operation, ELA funds scientific research programs, promotes early detection, and invests millions toward eradicating these conditions. The organization mobilizes communities, supports affected families, and collaborates with medical professionals and researchers to advance understanding and treatment of leucodystrophies.
| Brand Name | Association Européenne contre les Leucodystrophies (ELA) |
|---|---|
| Domain | ela-asso.com |
| Industry | Non-profit, Healthcare |
| Main Competitors | National MPS Society, United Leukodystrophy Foundation, Hunter's Hope Foundation, Myelin Project, NORD (National Organization for Rare Disorders) |
Moz Domain Authority 58/100 vs category average 36 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,340,242 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Bienvenue sur le site de l" (Meta description: 6 words. OG description present but brief) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:description, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, Instagram, Facebook, YouTube; no detected presence on X (Twitter), GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Association Européenne contre les Leucodystrophies (ELA) scores 27/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Association Européenne contre les Leucodystrophies (ELA) has a weak AI-visibility profile at 27/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (58/100) and its weakest is visibility (0/100). It benefits from a global traffic rank of #1,340,242 (Tranco), a Moz Domain Authority of 58/100 and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and thin schema.org structured data.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Association Européenne contre les Leucodystrophies (ELA)'s main competitors include National MPS Society, United Leukodystrophy Foundation, Hunter's Hope Foundation, Myelin Project, NORD (National Organization for Rare Disorders). These companies compete in the Non-profit space for similar customers, offering comparable products or services.
Sources: Association Européenne contre les Leucodystrophies (ELA) official site
Popular alternatives to Association Européenne contre les Leucodystrophies (ELA) include National MPS Society, United Leukodystrophy Foundation, Hunter's Hope Foundation, Myelin Project, NORD (National Organization for Rare Disorders). Each is an established option in the Non-profit space; the best fit depends on your specific needs, budget, and required features.
Sources: Association Européenne contre les Leucodystrophies (ELA) official site
Association Européenne contre les Leucodystrophies (ELA) has limited AI-search visibility, scoring 27/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 40, recommendation 58). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Association Européenne contre les Leucodystrophies (ELA) official site
ELA fights leucodystrophies by funding scientific research programs and promoting early detection in children. The organization invests millions into combating these rare genetic diseases and mobilizes communities to support its mission. It connects families affected by leucodystrophies with medical professionals and researchers, working collectively toward better diagnoses, treatments, and ultimately a cure. ELA also serves as an advocacy and support network for those impacted by these conditions.
Sources: Association Européenne contre les Leucodystrophies (ELA) official site
Association Européenne contre les Leucodystrophies (ELA) and National MPS Society are competitors in Non-profit. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Association Européenne contre les Leucodystrophies (ELA) official site
Based on the available facts, ELA does not offer commercial products. As a non-profit, its primary activities include funding scientific research programs focused on leucodystrophies and promoting early detection initiatives for children. It also provides a community and support network for families affected by leucodystrophies, as well as resources and collaboration opportunities for medical professionals and researchers. These services are oriented toward advocacy, research funding, and community support rather than commercial offerings.
Sources: Association Européenne contre les Leucodystrophies (ELA) official site
Association Européenne contre les Leucodystrophies (ELA) scores 58/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Non-profit options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Association Européenne contre les Leucodystrophies (ELA) official site
ELA is known for its long-standing commitment of over 30 years to combating leucodystrophies, a group of rare genetic diseases. The organization is recognized for funding numerous research programs and investing millions in the fight against these conditions. It is also known as the leading European association dedicated to eradicating leucodystrophies through a combination of scientific funding and community mobilization, making it a prominent voice in the rare disease advocacy space.
Sources: Association Européenne contre les Leucodystrophies (ELA) official site
ELA's primary audience includes families affected by leucodystrophies, who turn to the organization for support, information, and community connection. Medical professionals and researchers engaged in studying or treating leucodystrophies also engage with ELA, particularly in the context of research funding and collaboration. Additionally, supporters and advocates who care about children's health and rare disease causes form a key part of ELA's community, contributing to its mission of eradicating leucodystrophies.
Sources: Association Européenne contre les Leucodystrophies (ELA) official site
Association Européenne contre les Leucodystrophies (ELA) can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Association Européenne contre les Leucodystrophies (ELA) official site
ELA's popularity stems from its more than 30 years of dedication to a rare but devastating cause-leucodystrophies in children. By funding numerous research programs and investing millions, it has established itself as the premier European organization in this niche. Its ability to mobilize communities and connect families, medical professionals, and researchers around a shared mission has built a broad base of supporters and advocates who champion children's health and rare disease awareness.
Sources: Association Européenne contre les Leucodystrophies (ELA) official site
Ranked closest to Association Européenne contre les Leucodystrophies (ELA): Fundación DeClausura (71/100), Dataro (71/100), FrontStream (71/100), GrantVantage (71/100).
A step up - brands to learn from: Keela (81/100), Habitat for Humanity (81/100).
Category leader: Cleveland Clinic (95/100).